FDA Inspection 1107302 — Magellan Diagnostics, Inc.

Magellan Diagnostics, Inc. — FEI 1218996

The FDA completed an inspection of Magellan Diagnostics, Inc. on October 21, 2019 in North Billerica, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 21, 2019
Fiscal Year
2020
Product Type
Devices
Project Area
Compliance: Devices
Location
North Billerica, MA (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
333121 CFR 820.181DMR - not or inadequately maintained
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
73221 CFR 803.50(a)(2)Individual Report of Malfunction